1. Home
  2. FA vs BCRX Comparison

FA vs BCRX Comparison

Compare FA & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Advantage Corporation

FA

First Advantage Corporation

HOLD

Current Price

$12.63

Market Cap

2.3B

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.96

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FA
BCRX
Founded
2003
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.3B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
FA
BCRX
Price
$12.63
$8.96
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$15.67
$20.82
AVG Volume (30 Days)
884.3K
3.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
72.97
381.40
EPS
N/A
1.21
Revenue
$1,574,389,000.00
$25,186,000.00
Revenue This Year
$8.42
N/A
Revenue Next Year
$7.26
$12.55
P/E Ratio
N/A
$7.45
Revenue Growth
83.02
N/A
52 Week Low
$8.82
$6.00
52 Week High
$19.01
$11.31

Technical Indicators

Market Signals
Indicator
FA
BCRX
Relative Strength Index (RSI) 55.22 47.95
Support Level $12.10 $8.73
Resistance Level $12.78 $9.14
Average True Range (ATR) 0.53 0.37
MACD -0.00 -0.03
Stochastic Oscillator 44.44 40.54

Price Performance

Historical Comparison
FA
BCRX

About FA First Advantage Corporation

First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: